A thorough examination of the Muha Pharmaceuticals Master Case – specifically focusing on the legal breaches and subsequent fallout – reveals a deeply concerning pattern of misconduct. The analysis highlights systemic failures across multiple departments, including quality assurance and record-keeping. It's clear that company oversight was eith